Pharmacovigilance system strengthening has been identified by the Asia Pacific National Malaria Programs as a key priority to support vivax malaria elimination, through an extensive prioritization exercise conducted by the APMEN Vivax Working Group. In this webinar, a panel of experts from WHO, Thai FDA, and Drug Regulatory Authority of Pakistan (DRAP) discussed how pharmacovigilance of antimalarial drugs can be strengthened and integrated into research and routine public health systems. 

Facilitator -

• Dr. Caroline A. Lynch, Co-chair, APMEN VxWG and Regional Advisor, MMV, Chiang Mai, Thailand; 

Speakers/ Panellists -

• Dr. Shanthi Pal, Team Lead, Pharmacovigilance, World Health Organization, Geneva, Switzerland;

• Dr. Watcharee Rungapiromnan, Pharmacist, Health Product Vigilance Center, Thai Food and Drug Administration, Nonthaburi, Thailand;

• Dr. Obaidullah, Director, Drug Regulatory Authority of Pakistan, Islamabad, Pakistan.